Xenon Pharmaceuticals Inc. (XENE) Free cash flow 2016–2025
Xenon Pharmaceuticals Inc. (XENE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$279.9MFY2025 · since FY2016: -$19.8M → -$279.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$279.9M | -51.7% |
| FY2024 | -$184.5M | -17.7% |
| FY2023 | -$156.7M | -50.8% |
| FY2022 | -$103.9M | -45.2% |
| FY2021 | -$71.6M | -41.0% |
| FY2020 | -$50.8M | -752.6% |
| FY2019 | -$6.0M | +83.1% |
| FY2018 | -$35.2M | -21.3% |
| FY2017 | -$29.0M | -46.3% |
| FY2016 | -$19.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice